PITTSBURGH, Oct. 7, 2026 /PRNewswire/ -- Stock Preachers Market Commentary - Major averages split this week as the Nasdaq Composite and S&P 500 held onto gains while the Dow Jones Industrial Average and Russell 2000 turned lower. The Nasdaq rose 1.05% for the week to 27,475.93, and the S&P 500 added 0.92% to 7,793.85, even as both indices fell on the latest session. The Dow slipped 0.06% for the week to 51,145.98, and the Russell 2000 dropped 1.42% to 2,792.80, underscoring a market where large-cap tech and biotech names are carrying the tape while smaller companies lag. Active Companies from around the markets with current developments this week include: RTX (NYSE: RTX), Eli Lilly and Company (NYSE: LLY), SAP SE (NYSE: SAP), International Business Machines Corporation (NYSE: IBM), and Canadian National Railway Company (TSX: CNR) (NYSE: CNI).

The Nasdaq Composite closed at 27,475.93, down 0.45% on the day but still up 1.05% for the week, with an RSI14 of 64.5 signaling a market near overbought territory. The index traded as high as 27,722.75 this week, matching its 52-week high, while support sits at 27,288.79 and 27,167.06. The S&P 500 closed at 7,793.85, down 0.32% on the day, with RSI14 at 59.4 and resistance at its 52-week high of 7,844.52.

The Dow Jones Industrial Average fell 0.73% on the day to 51,145.98, pushing its weekly change to negative 0.06%, with an RSI14 of 40.4 reflecting the index's relative weakness. The Russell 2000 posted the week's sharpest decline, down 1.32% on the day and 1.42% for the week to 2,792.80, with an RSI14 of 34.5 as small caps underperform large caps.

Volatility ticked higher with the VIX at 15.33, up 0.32 on the day though down 0.19 for the week, while the Nasdaq-100 volatility gauge (VXN) rose to 21.45. In commodities, gold fell 1.25% on the day to $4,134.90 per ounce and silver dropped 1.51% to $60.24, while WTI crude slipped to $88.89 a barrel. Natural gas jumped 3.82% on the day, and the 10-year Treasury yield rose to 5.32%.

The full report includes a detailed levels ladder for each index, a broader look at sector sentiment, and a preview of what to watch in the week ahead.

CONTINUED... Read this and more news from around this sector and may more at: Stock Preachers Market Commentary

In other industry developments and happenings in the market this week include:

RTX (NYSE: RTX) Raytheon, an RTX business, has secured a five-year contract with two additional option years, valued up to $24.4 billion, for Standard Missile-6 (SM-6) interceptors, boosting availability of the munition for offensive strikes and missile defense missions for the U.S. Navy.

"SM-6's multi-mission capability is vital to our customer, and Raytheon is intensely focused on meeting the demand," said Phil Jasper, Raytheon President. "By continuously investing in our operations and facilities, we are removing constraints and boosting capacity to ensure we deliver this critical capability our sailors depend on."

SM-6 is described as the only combat-proven weapon able to perform anti-air warfare, anti-surface warfare and ballistic missile defense, and has been fired from various U.S. Navy ship-based platforms and land-based launchers.

Eli Lilly and Company (NYSE: LLY) The U.S. FDA has approved an additional indication for Jaypirca (pirtobrutinib), a non-covalent BTK inhibitor, for adult patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma without a known 17p deletion, allowing its use as a first-line treatment for appropriate patients.

The approval is based on the BRUIN CLL-313 trial, where at a median follow-up of 28 months, progression-free survival was significantly improved with pirtobrutinib compared to bendamustine plus rituximab (HR=0.20; p0.0001), with median PFS not yet reached for pirtobrutinib versus 33.5 months for the comparator arm. Overall response rate was 94% for pirtobrutinib versus 81% for the comparator.

"This milestone underscores Jaypirca's versatility in the CLL continuum of care, from the first-line setting for appropriate patients to its valuable role in the relapsed or refractory post-covalent BTK inhibitor setting," said Jacob Van Naarden, executive vice president and president of Lilly Oncology.

SAP SE (NYSE: SAP) SAP SE and TechWolf have entered into an agreement for SAP to acquire TechWolf, provider of an AI work intelligence platform that gives enterprises a continuously updated view of the work their people do and the skills they have. The deal is expected to close in the fourth quarter of 2026, subject to regulatory approval, with terms not disclosed.

"TechWolf's proprietary context graph for skills and work provides an excellent grounding layer for agent queries regarding work and skills planning and talent management," said Manoj Swaminathan, president and chief product officer for SAP Autonomous Suite and member of the Extended Board of SAP SE.

"We have spent eight years building the evidence layer to answer those questions," said Andreas De Neve, CEO and co-founder of TechWolf, who added the company plans to "build a world-class AI company" following the acquisition. TechWolf is expected to remain an independent entity under De Neve in its Ghent headquarters.

International Business Machines Corporation (NYSE: IBM) Hagens Berman is investigating potential securities law violations by IBM after CEO Arvind Krishna previewed disastrous Q2 2026 results on July 14, 2026, a disclosure that sent IBM shares down 25% in one day, erasing over $68 billion in market capitalization.

On April 22, 2026, IBM had reported Infrastructure, Hybrid Infrastructure, and IBM Z revenues up 15%, 28% and 51% respectively, with management projecting constant currency revenue growth of 5-plus percent for 2026. By July, total revenue growth had slowed to 1% and Infrastructure revenue declined 7%.

CEO Krishna said "[w]hat played out was worse than our expectations, driven by a shortfall in our Z performance and the associated software stack, primarily in Transaction Processing," adding "numerous large deals failed to close." "Based in part on the abruptness of the bad news, we are looking into whether and when the Company may have had information raising the probability that large deals were unlikely to timely close during IBM's second quarter," said Reed Kathrein, the Hagens Berman partner leading the investigation.

Canadian National Railway Company (TSX: CNR) (NYSE: CNI) CN announced it set a new quarterly record for grain movement, moving 7.94 million metric tonnes of grain from Western Canada in its third quarter, surpassing the previous record of 7.48 million metric tonnes set in 2020.

The company attributed the performance to robust customer demand, close collaboration across the grain supply chain and consistent execution of its operating plan, and said it remains focused on sustaining momentum through winter.

CN recently published its 2026-2027 Winter Plan outlining proactive solutions across its network to support safe and reliable service, and will report third-quarter 2026 financial and operating results before markets open on October 30, 2026.

Contact Information:

Media Contact: [email protected]

DISCLAIMER: Nothing in this article should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a market commentary and is not a paid advertisement. This article is being distributed by Stock Preachers, which is wholly owned and operated by Market Equities Limited ("MEL"), a company incorporated under the laws of Ireland. This is an independent market commentary published on a non-paid basis. MEL has not been paid any fee by any company mentioned in this article for its production or distribution, and MEL has no advertising or digital media agreement with any company mentioned in this article. The companies mentioned have not reviewed or approved this article. Market Equities and its owners, operators, directors, and affiliates may, from time to time, hold positions in securities mentioned in this article or in the broad-market index funds that track them, and reserve the right to buy, sell, or hold such securities at any time without further notice. Information in this article was obtained from sources believed to be reliable, including company news releases and public market data, but its accuracy cannot be guaranteed. Market data is as of the time stated and may be delayed. Portions of this commentary were produced with the assistance of automated tools from that data and reviewed against it. Investing in securities involves risk, including the possible loss of some or all of your investment. Technical analysis describes past price and volume behavior and does not predict future results; support and resistance levels can fail at any time. References to the companies named in this article are provided solely as market and sector context and as summaries of each company's own public news releases. No partnership, affiliation, or endorsement is implied, and nothing in this article is a recommendation to buy, sell, or hold any security. Quotations attributed to company executives are reproduced from those companies' own news releases. Forward-Looking Statements: This article may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements made by the companies mentioned in their own news releases. Such statements involve risks and uncertainties, and actual results may differ materially. Readers should review each company's filings with the SEC and applicable Canadian securities regulators.

In the news release, Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) supports Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month, issued 06-Oct-2026 by Alora Pharmaceuticals, LLC over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) supports Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month

ALPHARETTA, Ga., Oct. 6, 2026 /PRNewswire/ -- October marks ADHD Awareness Month, shining a light on the need for timely diagnosis and personalized treatment. Vertical Pharmaceuticals is dedicated to supporting the ADHD community and the importance of precision dosing.

Approximately 11.7% of U.S. children and adolescents in the United States have been diagnosed with ADHD, while adult diagnoses are estimated to be around 6%.1 Yet, despite this prevalence, misconceptions remain, especially for women, whose symptoms may be less visible and more easily overlooked. Common symptoms of ADHD include persistent patterns of inattention, hyperactivity, and impulsivity that can affect daily functioning.2

Clinically, ADHD presents uniquely in every individual and finding the right treatment and dose can make all the difference in achieving effective symptom control. Careful dose optimization of methylphenidate has been shown to provide significant symptom management benefits, especially in children, highlighting the need for ongoing medication management. This management is made easier by the availability of multiple tablet strengths.3

"Alora, Vertical Pharmaceuticals' parent company, is driven by a commitment to innovation and patient well-being, and we're proud to stand with the ADHD community by advancing therapies that make a meaningful difference in everyday life. RELEXXII gives providers the flexibility to titrate treatment with precision, supporting the unique needs of individuals impacted by ADHD."-Art Deas, CEO, Alora Pharmaceuticals

If you or a loved one is experiencing ADHD symptoms, we encourage you to have a conversation with your healthcare provider. Together with healthcare providers, who lead diagnosis and treatment, we support precision dosing so that patients can achieve the most effective, individualized care. At Vertical Pharmaceuticals, we are committed to helping the ADHD community thrive.

For further support, explore these trusted ADHD resources for patients and caregivers: ADDitude Magazine, American Academy of Child and Adolescent Psychiatry, American Professional Society of ADHD and Related Disorders, Children and Adults with Attention-Deficit Hyperactivity Disorder, National Institute of Mental Health, and The Attention Deficit Disorder Association.

For more information on RELEXXII® please visit relexxii.com. For Important Safety Information visit relexxii.com/isi. For full Prescribing Information, including BOXED WARNING, visit relexxii.com/pi. For U.S. residents only.

About Alora Pharmaceuticals, LLC

Headquartered in Alpharetta, GA, Alora Pharmaceuticals is a pharmaceutical company driven by a commitment to quality, reliability, and affordability. Alora Pharmaceuticals is the parent company of seven specialty pharmaceutical and pharmaceutical manufacturing companies with facilities in Texas and Georgia. The Alora family of companies includes Acella Pharmaceuticals, Avion Pharmaceuticals, Neuvosyn Laboratories, Osmotica Pharmaceuticals, Sovereign Pharmaceuticals, Trigen Laboratories, and Vertical Pharmaceuticals. With more than 550 employees, the Alora family of companies is proud to manufacture medicines in the United States, supporting domestic production, supply chain resilience, and patient access to affordable treatments.

Relexxii® is a registered trademark of Vertical Pharmaceuticals, LLC.

References: 1. https://mhstats.org/blog/how-many-people-have-adhd/ 2. https://www.cdc.gov/adhd/signs-symptoms/ 3. Childress AC, et al. Clin Pharmacol Drug Dev. 2025;0(0):1-7.

Correction: An earlier version of this release required an update to the ADDitude Magazine URL in the sixth paragraph.

SOURCE Alora Pharmaceuticals, LLC

Share this article

LONDON, Oct. 7, 2026 /PRNewswire/ -- The "Cold Plasma in Healthcare Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2032" report has been added to the Credence Research Inc. offering.

The global Cold Plasma in Healthcare Market was valued at USD 2,873 million in 2025 and is projected to reach USD 6,634 million by 2032, registering a CAGR of 12.7%. Growth is being supported by expanding clinical interest in non-thermal plasma for wound management, microbial control, dermatology, dental applications and device-related sterilization workflows. Point-of-care atmospheric systems are gaining importance because they can be deployed without high-temperature treatment, while device makers are increasingly pairing hardware with consumables, training and service support to improve treatment standardization.

Key Takeaways

- The Cold Plasma in Healthcare Market is projected to grow from USD 2,873 million in 2025 to USD 6,634 million by 2032 at a CAGR of 12.7%.

- Devices led the product segment with 68.4% share in 2025, reflecting the importance of installed treatment capability before recurring consumable and service revenue scales.

- Plasma Jet held 39.6% of the technology segment, while Atmospheric Pressure Cold Plasma accounted for 66.8% of the pressure-type segment in 2025.

- Wound Healing and Chronic Wound Management was the leading application with 28.9% share, supported by repeat-treatment workflows and strong clinical interest in microbial control.

- Hospitals represented 41.7% of end-user demand in 2025, while outpatient and specialty settings are emerging as important expansion channels.

- North America led with 38.9% share in 2025, followed by Europe at 31.2% and Asia Pacific at 21.0%.

Scope & Segmentation – Cold Plasma in Healthcare Market

The report provides a comprehensive analysis of the global Cold Plasma in Healthcare Market, covering revenue forecasts through 2032. It evaluates product models, plasma technologies, pressure formats, clinical applications, end-user settings, regional adoption and competitive development.

The study places particular emphasis on medically relevant cold-plasma platforms and clinically adjacent technologies, including suppliers active in medical devices, wound care, disinfection and other healthcare applications.

- The Cold Plasma in Healthcare Market is segmented based on product type, technology, pressure type, application, end user and region.

- By Product Type, the market includes Devices, Consumables, and Services and Software.

- By Technology, the market includes Dielectric Barrier Discharge, Plasma Jet, Radio-Frequency Cold Plasma, Microwave Cold Plasma, and Other Cold Plasma Technologies.

- By Pressure Type, the market includes Atmospheric Pressure Cold Plasma and Low-Pressure / Vacuum Cold Plasma.

- By Application, the market includes Wound Healing and Chronic Wound Management, Oncology Applications, Hemostasis and Blood Coagulation, Dentistry and Oral Care, Dermatology, Sterilization and Disinfection, Implant Surface Functionalization, and Plasma-Activated Liquids and Hydrogels.

- By End User, the market includes Hospitals, Ambulatory Surgical Centers, Wound Care Centers, Specialty Clinics, Research and Academic Institutes, and Home Care Settings.

- By Region, the market is analyzed across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Access crucial information at unmatched prices!

Request your sample report today and start making informed decisions powered by Credence Research Inc. https://www.credenceresearch.com/report/cold-plasma-in-healthcare-market

Why This Report Matters

- The report provides a focused view of a healthcare technology category moving from specialist use toward broader clinical and outpatient workflows.

- It helps decision-makers distinguish between cold-plasma device formats, pressure systems and application environments rather than treating plasma as a single technology class.

- The study highlights the importance of clinical evidence, training, service coverage and workflow fit in determining adoption speed.

- For medtech companies, hospitals, wound-care providers, distributors and investors, the report supports portfolio strategy, commercialization planning and regional market assessment.

Market Overview

- Industry Landscape and Value Chain Assessment

- Supply-Side Evaluation

- Demand-Side Evaluation

- Stakeholder Mapping

- Porter's Five Forces Review

- PESTLE Environment Assessment

- Market Forecast and Future Direction

- Short-Term Forecast, 0–2 Years

- Mid-Term Forecast, 3–5 Years

- Long-Term Forecast, 5–10 Years

- Market Entry and Expansion Strategy

Market Insights

- Clinical Adoption and Workflow Analysis

- Device and Consumables Economics

- Technology and Pressure-Type Benchmarking

- Application Opportunity Assessment

- Hospital and Outpatient Procurement Review

- Regulatory and Clinical Evidence Assessment

- Training and Service Infrastructure Review

- Regional Commercialization Analysis

- Investment Return and Market Expansion Assessment

Key Attributes

Segmentation

By Product Type

- Devices

- Consumables

- Services and Software

By Technology

- Dielectric Barrier Discharge

- Plasma Jet

- Radio-Frequency Cold Plasma

- Microwave Cold Plasma

- Other Cold Plasma Technologies

By Pressure Type

- Atmospheric Pressure Cold Plasma

- Low-Pressure / Vacuum Cold Plasma

By Application

- Wound Healing and Chronic Wound Management

- Oncology Applications

- Hemostasis and Blood Coagulation

- Dentistry and Oral Care

- Dermatology

- Sterilization and Disinfection

- Implant Surface Functionalization

- Plasma-Activated Liquids and Hydrogels

By End User

- Hospitals

- Ambulatory Surgical Centers

- Wound Care Centers

- Specialty Clinics

- Research and Academic Institutes

- Home Care Settings

By Region

- North America

- Europe

- Asia Pacific

- Latin America

- Middle East & Africa

Chronic Wound Burden and Point-of-Care Adoption Support Growth

Wound management remains the clearest commercial pathway for cold plasma because chronic and difficult-to-heal wounds require repeated interventions, infection control and standardized clinical workflows. Non-thermal systems are attractive where providers want localized treatment without heat-related tissue damage, and the repeat-treatment model can support sustained device utilization once protocols are established.

Atmospheric pressure platforms are particularly relevant to bedside and outpatient settings because they avoid vacuum infrastructure and can be packaged in mobile or compact formats. This supports adoption in wound-care centers, specialty clinics and hospital departments where portability and simple setup influence treatment throughput.

Device-Led Adoption Expands into Outpatient and Specialty Care

Capital equipment currently anchors the market, but installed-base expansion creates downstream opportunities for consumables, maintenance, training and software-enabled documentation. Vendors that provide protocol support and clinician education can lower adoption friction and improve treatment reproducibility across sites.

Beyond wound care, cold plasma is being evaluated or applied in dentistry, dermatology, sterilization, implant surface treatment and other specialty workflows. The commercial opportunity differs by application maturity, so credible clinical evidence and clear regulatory positioning remain central to market development.

Market Challenges Include Clinical Evidence Requirements, Procurement Scrutiny and Service Coverage

Healthcare buyers require clear evidence of safety, reproducibility and workflow value before scaling new treatment modalities. The evidence base is stronger in selected wound-care uses than in some emerging applications, which can lead to different adoption timelines across the segmentation.

Capital equipment procurement competes with other hospital priorities, making total cost of ownership, staff training, maintenance and local service availability important purchasing considerations. Limited support infrastructure can slow expansion in newer markets even when clinical interest is present.

Regulatory status and approved indications differ across devices and geographies. Suppliers must therefore avoid overextending claims and align commercialization with jurisdiction-specific approvals, clinical protocols and practitioner training.

Key Player Analysis

- terraplasma medical GmbH

- neoplas med GmbH

- Plasmacure B.V.

- Coldplasmatech GmbH

- Adtec Healthcare / Adtec Plasma Technology

- Viromed Medical AG

- relyon plasma GmbH

Recent Industry Developments

- In February 2025, Royal Wound-X, a division of Royal Biologics, entered a strategic partnership with Coldplasmatech GmbH focused on complex and chronic wound care using Cold Atmospheric Plasma technology.

- In April 2025, Viromed Medical AG signed an exclusive distribution agreement with UMECO Group covering commercialization of the ViroCAP and PulmoPlas cold-plasma medical devices in ten Asian markets.

- In June 2025, neoplas med introduced its Argon Cold Plasma Jet kINPen MED in Oman at a launch event in Muscat attended by healthcare professionals from public and private institutions.

Report Coverage

- The research report offers an in-depth analysis based on Product Type, Technology, Pressure Type, Application, End User and Region.

- It assesses device adoption, clinical workflow fit, consumables and service economics, regional commercialization and competitive positioning.

- The report distinguishes established and emerging applications and evaluates clinical evidence, procurement, training and regulatory factors that influence adoption.

- It provides strategic guidance for medical device companies, healthcare providers, distributors and investors assessing cold-plasma commercialization opportunities.

Access crucial information at unmatched prices!

Request your sample report today and start making informed decisions powered by Credence Research Inc. https://www.credenceresearch.

- Now approved by the U.S. Food and Drug Administration, this unique tablet design enables more precise, customizable dosing based on dog's weight, as well as improved convenience and cost-effectiveness.

- The new design for PREVICOX® tablets and packaging offers sustainability benefits, including storage up to one month in its container after tablet is divided, reducing waste as well as material use and supply complexity across the full product lifecycle.

JOHNS CREEK, Ga., Oct. 7, 2026 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, today announced the availability of the new Quarterable Snap-Tab design for PREVICOX® (firocoxib) Chewable Tablets, following approval from the U.S. Food and Drug Administration.

The new tablet design features double scoring to facilitate easier division of the tablet into quarters, enabling more precise and customizable dosing for a broader range of dogs based on weight. With this new scoring design, veterinarians can prescribe lower dosages for dogs as small as seven pounds, as well as more dosage options leveraging the new quarterable 57 mg and 227 mg chewable tablets.

PREVICOX® (firocoxib) is a COX-2 selective non-steroidal anti-inflammatory drug (NSAID) approved for the control of pain and inflammation associated with osteoarthritis in dogs and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs.1,2

"This new tablet design provides a number of benefits to veterinarians and dog owners, with the ability to more easily tailor dosing that can improve outcomes and ultimately enhance quality of life for more dogs," said Dr. Russ Drury, Executive Director, Veterinary Professional Services, Boehringer Ingelheim.

The new design also provides a number of benefits from a sustainability perspective. After the tablet is divided into quarters, it may be stored for up to one month in its packaging. The PREVICOX® bottle is changing as well, to an industry-standard round bottle, which will be taller. The cotton will be removed for optimal efficiency and reduced waste.

There are important aspects of PREVICOX® (firocoxib) Chewable Tablets that will remain the same, including the formulation, the full-tablet dose strengths of 57 mg and 227 mg, bottle counts, push and turn opening/closing system and child-resistant/senior-friendly characteristics.

These changes will be introduced progressively throughout 2026 and 2027, beginning with the PREVICOX® 227 mg x 60 count and PREVICOX® 57 mg x 60 count presentations.

About Boehringer Ingelheim – Animal Health business

Boehringer Ingelheim provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to have influence on people, animals, and society. Learn more at www.boehringer-ingelheim.com/animal-health.

About Boehringer Ingelheim

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com.

IMPORTANT SAFETY INFORMATION

PREVICOX® (firocoxib) Chewable Tablets are for use in dogs only. As a class, cyclooxygenase inhibitory NSAIDs like PREVICOX® may be associated with gastrointestinal, kidney, or liver side effects. Dogs should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with PREVICOX®, then monitored regularly while on therapy. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided or monitored closely.

References:

- PREVICOX® Summary of Product Characteristics (SPC) Veterinary Medicines Information website at: https://medicines.health.europa.eu/veterinary/en/600000000609.

- PREVICOX® information page at https://animalhealth.boehringer-ingelheim.com/pets/canine/products/therapeutics/previcox

PREVICOX® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc.

©2026 Boehringer Ingelheim Animal Health USA Inc., 4000 Medley Blvd., Suite 300 Johns Creek, GA 30097. All rights reserved. US-PET-0654-2026-A

SOURCE Boehringer Ingelheim Animal Health USA Inc.

Share this article

MIDDLETOWN, Del., Oct. 7, 2026 /PRNewswire/ -- The global Crane Tires Market was valued at USD 2.31 billion in 2025 and is projected to expand from USD 2.43 billion in 2026 to USD 3.63 billion by 2035, registering a compound annual growth rate of 4.56% during the forecast period, according to the latest market intelligence study published by Radial Insights.

Global infrastructure investment, renewable-energy construction and large industrial projects are expanding the operating base for mobile and all-terrain cranes. The market also benefits from crane rental fleet expansion and greater focus on tire life, heat control and reduced downtime as operators seek reliable products for highway travel and repeated jobsite repositioning.

The new "Crane Tires Market Size, CAGR & Forecast, 2025-2035" study spans 257 pages and evaluates the market by crane type, end user and brand tier. It covers all-terrain, rough-terrain, truck-mounted, crawler transport and pick-and-carry cranes, along with OEM, rental fleet, construction and oil and gas demand, regional performance, replacement dynamics, pricing and competitive positioning.

Construction and Infrastructure Investment Expands the Mobile Crane Tire Base

Construction and infrastructure activity is directly expanding the installed base of road-mobile lifting equipment. World Bank data cited in the Radial Insights study show private participation in infrastructure investment reached USD 100.7 billion in 2024, up 16% from 2023, while total U.S. construction activity reached a seasonally adjusted annual rate of USD 2.192 trillion in December 2024. These spending levels support crane deployment across highways, bridges, utilities and industrial projects.

Europe adds another source of project demand. In Great Britain, total new work output increased 1.4% in 2024 to a record GBP 140.7 billion, while annual new orders rose 5.6% and private infrastructure orders advanced 15.4%. Higher project activity increases utilization of all-terrain, rough-terrain and mobile construction cranes, supporting both original-equipment fitment and replacement demand.

Fleet purchases are following this workload. Liebherr said the Wittrock and Ulferts groups ordered 12 MK mobile construction cranes for delivery during 2024-25, ALL Family added the five-axle LTM 1100-5.3 in North America and Tadano customer Geo-Transport & Construction expanded to 21 units after taking new GR-1450EX cranes. Each fleet addition creates first-fit demand and a recurring aftermarket opportunity as cranes accumulate highway and jobsite hours.

Key Insights From Radial Insights' Crane Tires Study

- Asia-Pacific Leads Global Demand: Asia-Pacific accounted for 41.62% of the Crane Tires Market in 2025, supported by large construction programs, industrial development and expanding energy investment across China, India and Southeast Asia.

- All-Terrain and Rough-Terrain Cranes Drive Tire Demand: Mobile cranes lead the application base because infrastructure, wind energy and industrial projects require equipment that can travel efficiently while operating under heavy loads and difficult site conditions.

- Premium Brands Lead High-Performance Fitments: Michelin, Bridgestone and Goodyear hold strong positions in applications where fleets prioritize load capability, durability, heat management, safety and global service support.

- OEM and Replacement Demand Move Together: New crane purchases create first-fit tire demand, while high fleet utilization and frequent repositioning generate recurring replacement opportunities for rental companies, contractors and energy-sector operators.

- Infrastructure, Wind and Energy Projects Diversify Growth: Construction programs remain the primary demand engine, while wind-turbine installation and oil, gas and petrochemical megaprojects provide additional high-value applications for specialized crane tires.

Get Free Sample Report - https://www.radialinsights.com/report/crane-tires-market

Wind Energy Installation Surge Raises High-Capacity Tire Demand

Wind power development is becoming a significant demand engine because turbine erection relies on large mobile lifting fleets that travel between project sites. GWEC reported a record 117 GW of wind capacity installed globally in 2024. WindEurope recorded 16.4 GW of new capacity during the year, including 12.9 GW in the EU, with 84% onshore, while EUR 32 billion of investment was finalized for 20 GW of future projects.

Modern wind equipment increases the technical demands placed on crane fleets. U.S. Department of Energy data cited in the report show newly installed land-based turbines averaged 3.4 MW, 133.8 meters in rotor diameter and 103.4 meters in hub height in 2023. The U.S. offshore wind pipeline reached 80,523 MW in the 2024 Offshore Wind Market Report, supporting continued heavy-lift requirements as projects progress.

Liebherr positions the 1,200-tonne LTM 11200-9.1, with a 100-meter telescopic boom and nine axles, specifically for wind-turbine erection. Road-mobile all-terrain cranes can reduce setup and transport complexity between sites, but repeated highway travel and high axle loads create demanding tire duty cycles and support premium replacement demand.

Oil, Gas and Petrochemical Megaprojects Support Rough-Terrain Demand

Oil, gas and petrochemical construction provides another high-value demand pool because these projects require heavy module lifts and repeated equipment repositioning. Aramco said in June 2024 that it awarded more than USD 25 billion of contracts for its gas expansion program, including phase two of Jafurah, phase three of the Master Gas System, approximately 4,000 kilometers of pipelines and 17 new gas compression trains. Jafurah lifecycle investment is expected to exceed USD 100 billion.

In Abu Dhabi, ADNOC's Ruwais LNG project received an EPC notice in March 2024 and is being developed with two 4.8 mmtpa liquefaction trains. ADNOC Gas later awarded USD 2.1 billion of enabling contracts in January 2025, while ADNOC Refining has a USD 3.47 billion Crude Flexibility project in development. Programs of this scale sustain crane utilization over multiple phases.

Rough-terrain and all-terrain cranes are particularly relevant where heavy lifting must be combined with mobility inside congested energy sites. Manitowoc's five-axle Grove GMK5150XL was selected for gas-platform work in Azerbaijan because its 68.7-meter boom reduces jib use and setup time. These applications reward tires with high load ratings, heat resistance, stability and dependable roadability.

Fleet Expansion and High Utilization Sustain Replacement Demand

OEM crane manufacturers and rental fleet operators represent the largest end-user groups, while contractors and oil and gas companies add specialized demand. Radial Insights notes that global crane utilization rates exceeded 85% during 2024-25, increasing the value of tire availability and lifecycle performance. Rental fleets are especially sensitive to downtime, encouraging premium products and structured maintenance programs.

Procurement is therefore shifting toward total cost of ownership rather than upfront price alone. Fleet managers evaluate tire life, retreadability, rolling resistance, maintenance intervals and aftersales support, while telematics can help monitor wear and schedule replacement before disruption occurs. Suppliers combining durable products with regional inventory and technical service are positioned to capture a larger share of first-fit and replacement demand.

Crane Tires Market Snapshot, 2025-2035

Market Challenges

Raw material volatility and supply-chain concentration remain important risks because crane tires depend on natural rubber, synthetic polymers and steel cord. The report identifies geopolitical instability in Southeast Asia as a potential source of disruption, while port congestion and container shortages can extend lead times. Multi-supplier sourcing, inventory planning and regional stock availability are therefore increasingly important.

Regulatory compliance also raises development and market-entry costs. Suppliers must address quality, commercial tire and chemical-safety requirements that can include ISO 9001, ECE R54 and REACH, while environmental rules and trade measures can influence compounds and landed pricing. Global manufacturers must maintain consistent certification without slowing fitment expansion.

Pricing pressure creates a further challenge because premium products command higher prices for advanced materials, tread designs and OEM approvals, while Tier 2 and regional brands compete aggressively for cost-sensitive fleets. Buyers increasingly compare upfront price with expected life, downtime risk and service availability, making measurable lifecycle performance essential for defending margins.

Recent Industry Developments

- In March 2025, Magna Tyres unveiled the Magna M-CRANE at BAUMA 2025, introducing a next-generation mobile crane tire with 178F and 170F ratings, enhanced structural durability and a five-year limited warranty. The launch raises the performance benchmark for load capacity, heat control and lifecycle value in demanding highway and jobsite operations.

- In May 2025, Michelin launched the X-CRANE 2 in 445/95 R 25, extending its portfolio for mobile and all-terrain cranes. The tire uses a 178F load and speed index, is 5% lighter than the prior model and supports 800 kilograms more load per tire at 80 kph, addressing fleet requirements for faster travel, higher payload efficiency and safer braking.

- In April 2026, Techking used CONEXPO 2026 to engage OEM partners on application-specific tire solutions for all-terrain cranes, emphasizing uptime, durability, stability and total cost of ownership. Earlier supplier-OEM collaboration can accelerate fit-for-purpose development, strengthen original-equipment adoption and raise technical standards across crane fleets.

LONDON, Oct. 7, 2026 /PRNewswire/ -- The "Thermal Spray Coating Market – Growth, Share, Opportunities & Competitive Analysis, 2024–2032" report has been added to the Credence Research Inc. offering.

The global Thermal Spray Coating Market was valued at USD 10,581.2 million in 2023 and is projected to reach USD 16,414.9 million by 2032, registering a CAGR of 5.00% during the forecast period. Growth is supported by demand for wear, corrosion and thermal protection across aerospace, automotive, energy, industrial and medical applications. Greater use of robotic spray systems, continued development of HVOF and plasma spray processes, and broader availability of engineered metallic and ceramic feedstocks are improving coating repeatability and expanding the range of components that can be economically protected or refurbished.

Key Takeaways

- The Thermal Spray Coating Market is projected to rise from USD 10,581.2 million in 2023 to USD 16,414.9 million by 2032 at a CAGR of 5.00%.

- Plasma spray coating held the largest process share at approximately 35-40% in 2023, while HVOF is positioned for faster growth as users seek dense, wear-resistant coatings.

- Metallic coatings represented approximately 40-45% of the market in 2023, while ceramic coatings are gaining importance in thermal, electrical insulation and high-temperature applications.

- Aerospace and defense was the leading application at roughly 35-38% in 2023, supported by protection requirements for high-value components operating under severe thermal and mechanical conditions.

- North America led the market in 2023, supported by established aerospace, defense, automotive and industrial coating ecosystems.

- Automation, digital process control and multi-process spray platforms are becoming important differentiators for coating quality, productivity and traceability.

Scope & Segmentation – Thermal Spray Coating Market

The report provides a comprehensive analysis of the global Thermal Spray Coating Market, covering revenue forecasts through 2032. It evaluates process technology, material composition, application demand, regional trends, competitive positioning and the operating factors shaping adoption of engineered surface protection.

The study examines plasma spray, HVOF, wire arc, flame spray and cold spray technologies, along with metallic, ceramic and composite coatings. It also assesses demand from aerospace and defense, automotive, energy, oil and gas, industrial manufacturing and medical applications where component life, heat resistance, wear protection and corrosion control influence procurement.

The Thermal Spray Coating Market is segmented based on type of thermal spray process, material composition, application and geography.

- By Type of Thermal Spray Process, the market includes Plasma Spray Coating, High-Velocity Oxy-Fuel (HVOF) Coating, Wire Arc Spray Coating, Flame Spray Coating and Cold Spray Coating.

- By Material Composition, the market includes Ceramic Coatings, Metallic Coatings and Composite Coatings.

- By Application, the market includes Aerospace and Defense, Automotive, Energy and Power Generation, Oil and Gas, Industrial and Manufacturing, and Medical and Healthcare.

- By Geography, the market is analyzed across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Access crucial information at unmatched prices!

Request your sample report today and start making informed decisions powered by Credence Research Inc. https://www.credenceresearch.com/report/thermal-spray-coating-market

Why This Report Matters

- The report provides a focused view of a surface engineering market tied directly to asset life, component reliability and maintenance economics.

- It helps decision-makers compare spray processes and material systems against application requirements such as wear, corrosion, heat exposure and dimensional restoration.

- The study evaluates how automation and advanced process control are changing coating consistency, throughput and qualification requirements.

- For coating suppliers, equipment manufacturers, OEMs, MRO providers and investors, the report supports technology positioning, capacity planning and market-entry decisions.

Market Overview

- Industry Landscape and Value Chain Assessment

- Supply-Side Evaluation

- Demand-Side Evaluation

- Stakeholder Mapping

- Porter's Five Forces Review

- PESTLE Environment Assessment

- Market Forecast and Future Direction

- Short-Term Forecast, 0–2 Years

- Mid-Term Forecast, 3–5 Years

- Long-Term Forecast, 5–10 Years

- Market Entry and Expansion Strategy

Market Insights

- Customer and End-User Analysis

- Process Technology Benchmarking

- Material Composition Assessment

- Growth Opportunity Assessment

- Pricing and Raw Material Movement Analysis

- Automation and Robotics Adoption Review

- Regulatory and Environmental Assessment

- Competitive Positioning Analysis

- Investment Return and Market Expansion Assessment

Key Attributes

Segmentation

By Type of Thermal Spray Process

- Plasma Spray Coating

- High-Velocity Oxy-Fuel (HVOF) Coating

- Wire Arc Spray Coating

- Flame Spray Coating

- Cold Spray Coating

By Material Composition

- Ceramic Coatings

- Metallic Coatings

- Composite Coatings

By Application

- Aerospace and Defense

- Automotive

- Energy and Power Generation

- Oil and Gas

- Industrial and Manufacturing

- Medical and Healthcare

By Geography

- North America

- Europe

- Asia Pacific

- Latin America

- Middle East & Africa

Market Growth Driven by High-Performance Surface Protection Demand

Aerospace, energy and industrial operators continue to use thermal spray coatings to protect high-value parts against wear, oxidation, corrosion and extreme temperatures. The ability to rebuild or protect surfaces without replacing an entire component strengthens the economic case for thermal spray in MRO-intensive sectors and in applications where component downtime is costly.

Aerospace and defense remains a core application because turbine, propulsion and structural components require tightly controlled coating properties. Automotive, oil and gas, power generation and medical applications add diversified demand, reducing dependence on a single end market and supporting steady investment in process qualification and specialized coating materials.

Robotic Thermal Spray and HVOF Systems Strengthen Production Consistency

Robotic manipulation and digitally controlled spray platforms are increasing repeatability across complex geometries. Automated systems can improve stand-off distance, traverse speed and deposition consistency while reducing operator exposure and material waste, which supports adoption in high-volume and tightly specified production environments.

HVOF is gaining attention where dense coatings and strong wear or corrosion resistance are required, while plasma spray retains broad applicability across metallic and ceramic feedstocks. Multi-process platforms that combine automation, process monitoring and flexible part handling are helping coating shops serve wider component ranges without sacrificing control.

Market Challenges Include Raw Material Volatility, Process Complexity and Alternative Coating Technologies

Thermal spray operations remain sensitive to feedstock prices, energy costs and availability of specialized powders, wires and gases. Changes in input costs can pressure margins when qualification requirements limit the ability to switch materials quickly.

Equipment, ventilation, robotics and process-control requirements can create meaningful capital and technical barriers. Skilled operators and engineers remain important because coating performance depends on surface preparation, parameter control, powder characteristics and application-specific qualification.

PVD, CVD, advanced powder coatings and other surface treatment technologies compete in selected applications. Thermal spray suppliers therefore need to demonstrate lifecycle economics, coating performance and process reliability rather than compete on deposition cost alone.

Key Player Analysis

- Oerlikon Metco

- Höganäs AB

- Castolin Eutectic

- Wall Colmonoy Corp.

- Saint-Gobain Coating Solutions

- Fujimi Inc.

- Kennametal Stellite

- Kymera International

Recent Industry Developments

- In July 2025, Oerlikon Metco launched Surface Two, an IIoT-enabled thermal spray platform designed for larger parts and broader industrial applications, with support for plasma spray, HVOF and combustion powder spray configurations.

- In December 2024, Kymera International acquired Coating Center Castrop GmbH in Germany, expanding its European surface technologies footprint and adding advanced thermal spray and precision machining capabilities.

Report Coverage

- The research report offers an in-depth analysis based on Thermal Spray Process, Material Composition, Application and Geography, with market sizing and forecasts through 2032.

- It evaluates process adoption, material selection, end-user demand, competitive positioning and the role of automation in coating quality and productivity.

- The report examines market drivers, technology trends, operational constraints, raw material exposure and competition from alternative coating methods.

- It provides strategic guidance for coating suppliers, equipment manufacturers, OEMs, MRO providers and investors assessing growth opportunities in surface engineering.

Access crucial information at unmatched prices!

Request your sample report today and start making informed decisions powered by Credence Research Inc. https://www.credenceresearch.com/report/thermal-spray-coating-market

Shape Your Report to Specific Countries or Regions and Enjoy 30% Off!

Customize Now

Related Reports –

https://www.credenceresearch.com/report/aerospace-coatings-market

https://www.credenceresearch.com/report/marine-coatings-market

https://www.credenceresearch.com/report/sorbitan-ester-market

https://www.credenceresearch.com/report/sonar-absorbing-rubber-composites-market

https://www.credenceresearch.

Partnership signed at LEAP 2026 will develop and commercialize industrial-grade AI agents targeting capital productivity, supply chain performance and operational execution

RIYADH, Saudi Arabia, Oct. 7, 2026 /PRNewswire/ -- OrbitronAI and Aramco Digital have formed a strategic commercial partnership to develop, deploy and commercialize industrial-grade agentic AI solutions focused on industrial value recovery across asset-intensive industries. The agreement was signed in early September at LEAP 2026 in Riyadh.

The partnership combines OrbitronAI's industrial-grade agentic AI technology and domain-led delivery model with Aramco Digital's industrial knowledge, operating scale and market reach. The companies will target multibillion-dollar value pools in areas including capital productivity, supply chain performance and operational execution, where fragmented information, complex workflows and delayed decisions can materially affect financial performance.

In capital-intensive environments, delays in reviews, reconciliation and decision-making can affect schedule, cost and returns on invested capital. In supply chains, limited visibility across materials, suppliers and logistics can increase cost, tie up working capital and disrupt operations. OrbitronAI's technology is built for these environments. It works across structured and unstructured industrial information, connects with enterprise systems and combines agentic reasoning with deterministic execution, while critical calculations, controls and approvals remain governed and subject to human oversight.

"Together with Aramco Digital, we are building a repeatable model for industrial value recovery: take a high-value industrial process, embed industrial-grade agents into the workflow, recover the value and turn what works into a product that can scale across the industry."

— Saulius Adomaitis, Co-Founder and CEO, OrbitronAI

"Aramco Digital is focused on areas where our industrial knowledge, scale and data create a clear advantage. Capital projects, supply chain and other asset-intensive processes represent major opportunities to improve execution and create economic value. Through our partnership with OrbitronAI, we intend to convert that industrial advantage into scalable AI products for Aramco, our affiliates and the wider industrial market."

— Ashraf Tahini, CEO, Aramco Digital

Successful capabilities developed through the partnership will be designed for reuse across similar industrial processes, creating a path to commercialization across Saudi Arabia and selected international markets.

OrbitronAI's founding team combines industrial operating and technology experience. Luvy Singh, Co-Founder and Chief Business Officer, previously led supply chain at Shell and was a partner at EY. Ashu Gupta, Co-Founder and Chief AI Officer, was a founding CTO at a leading fintech company, while Poonam Gupta, Co-Founder and CTO, leads the engineering of OrbitronAI's industrial-grade agentic AI platform.

###

About OrbitronAI

OrbitronAI builds secure, industry-specific AI systems for enterprises running complex operations. At its core is NovaOS, a proprietary agentic operating layer that connects existing enterprise systems, orchestrates AI workflows and provides the governance, oversight and auditability needed to deploy AI agents safely at scale. OrbitronAI works mainly with aviation, transport, energy and infrastructure organizations. It supports critical functions including supply chain, compliance, asset maintenance, sales and marketing, and helps clients reduce manual work, make better decisions and manage operational risk. With more than 50 people across five global offices, the company combines deep industry expertise with advanced AI engineering. OrbitronAI is ISO 27001 certified and SOC 2 compliant.

Learn more at www.orbitronai.com

Media Contact

Vilma Vaitiekunaite

GM, OrbitronAI KSA

E  [email protected]

T  +966 56 778 9790

SOURCE OrbitronAI

Share this article

SHERIDAN, Wyo., Oct. 7, 2026 /PRNewswire/ --

How big is the animal feed market, and what's driving its growth?

The global animal feed market is valued at USD 672.5 billion in 2026 and is projected to reach USD 826.1 billion by 2031, growing at a CAGR of 4.2% over the forecast period, according to a new study by Wissen Research.

Behind that number is a bigger story: livestock supplies roughly 34% of the world's food protein, and nearly every pound of meat, liter of milk, or egg carton on a shelf starts with a scientifically formulated feed ration. As global demand for meat, milk, eggs, and aquaculture products keeps climbing, and as farms worldwide shift away from mixing their own feed toward commercially manufactured compound feed, producers across poultry, swine, cattle, dairy, and aquaculture are relying more than ever on precision-formulated nutrition to improve animal health, productivity, and feed conversion.

Get a Free Sample of This Report to Explore Key Findings and Data: https://www.wissenresearch.com/request-a-sample/?report=animal-feed-market

Precision Nutrition and Alternative Proteins Reshape Commercial Feed Production

The animal feed industry is moving from conventional, commodity-based manufacturing toward a more technology-driven approach to animal nutrition. Feed manufacturers are increasingly integrating near-infrared spectroscopy (NIR), automated batching and dosing systems, and digital feed-management platforms into commercial production, allowing them to optimize nutrient utilization, improve feed conversion ratio, and reduce nutrient losses with far greater precision than traditional formulation methods allowed.

Alongside this technological shift, the industry is actively diversifying its raw-material base. Insect protein, algae, single-cell proteins, fermentation-derived ingredients, and agricultural by-products are being evaluated for their nutritional and environmental characteristics, particularly in aquafeed, poultry, and premium animal-nutrition applications, as manufacturers work to reduce dependence on conventional feed commodities. At the same time, growth in enzyme technologies, probiotics, organic minerals, and phytogenics is helping producers support gut health and animal performance while responding to tightening restrictions on antibiotic use, accelerating demand for antibiotic-free feed additive alternatives across livestock production.

Aquaculture's Rising Share of Specialized Feed Demand

Aquaculture is expanding rapidly as seafood demand rises and wild fish stocks come under growing strain, creating sustained demand for species-specific aquafeed formulations. Feed producers are tailoring protein, fat, amino acid, vitamin, and mineral profiles to individual species, growth phases, and farming practices, with shrimp, salmon, tilapia, and carp each requiring distinct nutritional formulations. Extruded and pelleted feed forms are gaining preference for their nutrient supply, buoyancy control, and water stability, while mycotoxin detoxifiers, probiotics, and prebiotics are increasingly used to reduce disease-related losses and improve feed utilization efficiency in aquaculture operations.

What's Fueling Growth in the Animal Feed Market

- Rising Animal Protein Consumption: Population growth, urbanization, and changing diets are driving higher production of meat, milk, eggs, and seafood, directly increasing feed consumption.

- Industrialization of Livestock Production: The shift from traditional farm-mixed rations toward commercially manufactured compound feed is accelerating, particularly across emerging Asian markets.

- Poultry and Aquaculture Expansion: Rapid growth in broiler, layer, and aquaculture production is driving demand for specialized, commercially formulated nutrition products.

- Feed Efficiency and Animal Health Focus: Growing adoption of enzymes, probiotics, phytogenics, amino acids, and organic minerals is improving nutrient utilization and supporting producers navigating antibiotic-use restrictions.

- Commercial Feed Capacity Expansion: Growing manufacturing capacity across developing markets is improving access to formulated feed, with Asia alone producing approximately 559.3 million tons of feed in 2025.

Challenges Facing the Animal Feed Market

Ingredient cost volatility remains one of the sector's most persistent pressures. Fluctuations in the price and availability of corn, wheat, soybean meal, fishmeal, and oils, driven by weather conditions, crop yields, geopolitical developments, trade restrictions, and competing demand from food and industrial uses, can materially affect feed economics and squeeze manufacturer margins.

Feed safety presents a further challenge, since contaminated or nutritionally inadequate feed can affect animal health, productivity, food safety, and international trade. Mycotoxins, chemical residues, and pathogens require robust testing, quality assurance, and traceability systems, adding operational complexity and cost. Sustainability pressure is also intensifying, as manufacturers and producers face growing expectations to reduce resource use, improve feed conversion, and lower the environmental footprint of livestock production.

Recent Strategic Developments in the Animal Feed Market

In July 2026, De Heus Animal Nutrition B.V. of the Netherlands expanded its aquaculture feed capabilities by opening a 168,000-tonne-per-year marine and cold-water fish feed mill in Vietnam, producing specialized feed for species including sea bass and barramundi to support regional and export markets.

In June 2026, Archer-Daniels-Midland Company opened a new premix and feed additives production facility in Apucarana, Brazil, with an annual capacity of approximately 40,000 tons, incorporating advanced automation, mixing precision, and traceability technologies to support customized formulations across Brazil's animal nutrition market.

These moves reflect an industry where major manufacturers continue to invest in specialized, high-value production capacity, particularly in aquaculture and premix/additive manufacturing, as a way to serve both regional demand and export markets.

Key Insights from Animal Feed Market Analysis

- Cereals held the largest share by ingredient type in 2025, led by corn, wheat, barley, and sorghum, which provide the primary energy component across poultry, swine, and cattle feed formulations.

- Amino acids held the largest share by additive type in 2025, widely used across poultry, swine, and aquaculture diets to balance dietary protein and improve nutrient utilization.

- Asia Pacific held the largest regional share in 2025 and remains the fastest-growing region, with feed production in the region estimated at approximately 533.1 million metric tons in 2024; China alone produced approximately 315 million tonnes of industrial feed that year.

- The global commercial feed industry produces more than 1 billion tonnes of feed annually, generating approximately USD 400 billion in commercial turnover, with global feed protein consumption projected to rise 13.5% over the coming decade according to the OECD-FAO Agricultural Outlook 2026–2035.

Key Players in the Animal Feed Market

Leading companies in the animal feed market are focused on feed-production capacity expansion, precision nutrition, feed additives, animal health, alternative ingredients, aquaculture nutrition, and digital feed-management technologies to strengthen their market position.

Regional Analysis and Growth Opportunities

Asia Pacific leads the animal feed market, supported by a large livestock and poultry production base, an expanding aquaculture industry, and substantial feed-manufacturing capacity. China remains the region's largest feed-producing country, while India, Southeast Asia, and other Asian markets are supported by expanding poultry, dairy, swine, and aquaculture sectors. In India specifically, commercial feed accounts for approximately 60% of the total animal feed market, with poultry representing about 75 to 78% of commercial feed demand, underscoring how rapidly commercial feed is displacing traditional farm-mixed rations across the region.

North America, Europe, Latin America, and the Middle East & Africa complete the report's regional coverage, with growth supported by continued intensification of livestock production and rising adoption of functional and precision-nutrition feed products.

Get a Custom Briefing on This Market for Your Business

Wissen Research's analysts are available to walk through findings specific to your market, region, or competitive set.

Need Insights Specific to Your Business? Request a Customized Version of This Report: https://www.wissenresearch.com/request-customization/?report=animal-feed-market

Market Segmentation Snapshot

The global animal feed market is segmented across ingredients type, additive type, animal type, source type, form type, and region:

- By Ingredients Type: 

- Cake & Meals

- Cereals

- By-Product

- By Additive Type: 

- Acidifiers

- Carotenoids

- Enzymes

- Mycotoxin Detoxifiers

- Flavors & Sweeteners

- Antibiotics

- Minerals

- Amino Acids

- Phosphates

- Vitamins

- Antioxidants

- Non-Protein Nitrogen

- Preservatives

- Phytogenics

- Probiotics

- By Animal Type: 

- Poultry (Broilers, Layers, Breeders)

- Ruminants (Calves, Dairy Cattle, Beef Cattle, Other Ruminants)

- Swine (Starters, Growers, Sows)

- Aquatic Animals

- Pets and Others

- By Source Type: 

- Synthetic

- Natural

- By Form Type: 

- Pellets

- Mash

- Crumbles

- By Region: 

- North America

- Europe

- Asia-Pacific

- Latin America

- Middle East & Africa

Frequently Asked Questions

Q: What is the size of the animal feed market? A: The global animal feed market is estimated at USD 672.5 billion in 2026 and is projected to reach USD 826.1 billion by 2031.

Q: What is the growth rate of the animal feed market? A: The animal feed market is projected to grow at a CAGR of 4.

Recognized among 50 women for leadership, entrepreneurship and commitment to developing future leaders

NEWARK, N.J., Oct. 7, 2026 /PRNewswire/ -- Cheryl McCants, Founder and CEO of Impact Consulting Enterprises, has been named one of 50 inaugural Women to KNOW in New Jersey, recognizing her nearly four decades of entrepreneurship, corporate and civic leadership, strategic communication, community impact and commitment to developing future leaders. McCants was honored at the Women to KNOW in New Jersey Dinner & Gala on October 6 at 18 Label in Montclair.

Presented by KNOW Women, the recognition celebrates accomplished women across New Jersey whose professional achievements, leadership and community impact are helping shape New Jersey's future. McCants' career spans entrepreneurship, corporate leadership, public service and strategic consulting, with work across business, government, education, healthcare, life sciences and mission-driven organizations.

"This recognition reflects so many dimensions of my journey — building a business, leading through change, serving my community and helping other people recognize the power of their own ideas and voices," said McCants. "As the mother of a daughter, developing the next generation of women leaders is deeply personal to me. Through The Impact Institute, I am building on my experience to help others strengthen their voices, develop their skills and create their own paths forward."

McCants Makes the Invisible Visible®, helping businesses, organizations and communities turn ideas into meaningful action. Her career includes leadership roles with Nike and Jordan Brand, public service as a former town commissioner, and service on business, education and economic-development boards. Through each chapter, she has focused on elevating overlooked ideas and voices, creating opportunity and helping organizations move from strategy to action.

Through the Impact Institute, McCants and her team provide workforce development, professional growth and skill-building in writing, speaking and strategic thinking. Her podcast, "Build Your Brand with Cheryl McCants: Make the Invisible Visible®," brings her experience directly to business owners with practical insight on branding, marketing, leadership, visibility and growth.

McCants credits her late aunt, Alma Williams, with profoundly shaping her approach to leadership. "My Aunt Alma's mantra, 'Nothing ever happens wrong,' taught me to find possibility in setbacks, adapt and keep moving," said McCants. "She taught me to see what others might overlook — a philosophy embedded in my commitment to Make the Invisible Visible."

About Impact Consulting Enterprises – www.eimpactconsulting.com

Impact Consulting Enterprises is a full-service marketing communication and strategic consulting firm that helps organizations Make the Invisible Visible®. For more than 35 years, Impact has developed integrated communication, public relations, marketing, research and engagement strategies for corporations, government agencies, educational institutions, healthcare and life sciences organizations, and mission-driven enterprises. The firm helps clients translate complex ideas into clear strategies, compelling stories and meaningful action.

About The Women to KNOW in New Jersey – https://theknowwomen.com/new-jersey

The Women to KNOW in New Jersey is part of KNOW Women's state-based recognition program, which features high-achieving women through its media, publications and events. Its mission is to elevate and connect women whose work shapes industries and communities.

Image of McCants can be found here: https://www.dropbox.com/scl/fi/ukup45aanjpy80eygdawg/Cheryl-McCants-KNOW-NJ.png?rlkey=5kz4ob7mgklhr1h82820r1jfc&st=8d83cgp9&dl=0

SOURCE Impact Consulting Enterprises LLC

Share this article

DC Market Insights forecasts 7.43% CAGR through 2035; Kubernetes-native virtualization grows 21.29% annually while North America holds 40.6% of 2025 market value

LONDON, Oct. 7, 2026 /PRNewswire/ -- The global Data Center Virtualization Market was valued at $29.75 billion in 2025 and is projected to reach $60.90 billion by 2035, expanding at a compound annual growth rate of 7.43%, according to a new study from DC Market Insights. The market is moving into a new phase in which platform diversification, licensing economics, Kubernetes-native infrastructure and higher demand for migration and managed services are reshaping how enterprises and data center operators deploy virtualized compute.

View the full report: https://www.dcmarketinsights.com/report/data-center-virtualization-market

Virtualized Core Growth and Licensing Changes Drive Market Expansion

DC Market Insights identifies three forces behind most of the market's growth: expansion of the virtualized physical core base, higher software spend per core following licensing changes and a sustained wave of upgrade and migration projects. The firm models the installed virtualized core base rising from about 92.0 million in 2025 to 155.75 million by 2035. Server virtualization software alone is forecast to increase from $14.90 billion to $28.45 billion over the same period.

The report also finds that average server virtualization software spend increased from about $136 per core in 2023 to $162 per core in 2025. That price reset contributed significantly to the market's 2025 value expansion. Looking ahead, growth becomes more volume- and service-driven as enterprises add cores, automate mixed infrastructure and outsource a larger share of ongoing operations.

Multi-Hypervisor Strategies Move Into the Mainstream

The competitive structure of virtualization is broadening. Proprietary Type 1 hypervisors accounted for 71.8% of market value in 2025, but their share is projected to decline to 53.5% by 2035. Open-source and KVM-based hypervisors are forecast to grow from $6.72 billion in 2025 to $16.83 billion by 2035, a 9.61% CAGR, while Kubernetes-native virtualization is the fastest-growing hypervisor category at 21.29% annually, increasing from $1.67 billion to $11.48 billion.

This shift does not imply the disappearance of established proprietary platforms. Instead, the report points to a more diversified operating model in which large buyers maintain core estates on established platforms while deploying new or less critical workloads on KVM-based, hyperconverged or Kubernetes-native alternatives. That architecture raises demand for cross-platform management, policy automation, skills, migration tooling and services.

Server Virtualization Software Retains the Largest Component Share

Server virtualization software represented 50.1% of global market revenue in 2025 at $14.90 billion. Professional services accounted for $4.15 billion, desktop and application virtualization for $4.66 billion, virtualization management and orchestration for $3.50 billion and managed services for $2.54 billion.

Managed services are projected to record the strongest growth among components, advancing at 11.70% annually to $7.67 billion by 2035. Virtualization management and orchestration also grows faster than the overall market, reaching $8.03 billion by 2035 as operators automate patching, policy enforcement, lifecycle management and capacity planning across several hypervisors.

On-Premises Enterprise Data Centers Lead, but Hosted and Edge Models Gain Share

On-premises enterprise data centers were the largest deployment segment in 2025 at $15.59 billion, or 52.4% of global spending. Colocation and hosted private cloud represented 23.6%, cloud service provider data centers 17.4% and edge and remote sites 6.6%. Edge and remote deployments are forecast to grow fastest at 11.90% annually, reaching $6.05 billion by 2035.

Large enterprises accounted for 69.3% of market value in 2025, while small and medium enterprises are projected to grow faster through hosted, managed and subscription-based offerings. Banking, financial services and insurance was the largest end-user vertical at 22.6% of spending, followed by IT and telecom. Healthcare is forecast to be the fastest-growing major vertical as hospitals virtualize clinical applications, shared workstations and data-intensive workloads.

North America Leads; Asia Pacific Gains the Most Share

North America led the market with $12.08 billion in 2025, representing 40.6% of global value, and is forecast to reach $22.42 billion by 2035. The region has the largest installed base of proprietary hypervisors and is therefore seeing a significant volume of licensing reviews, platform renewals and migration projects.

Europe held 27.8% of the market in 2025 at $8.27 billion, while Asia Pacific accounted for 23.4% at $6.96 billion. Asia Pacific is projected to reach $16.92 billion by 2035 at a 9.29% CAGR, gaining 4.4 percentage points of global share. The Middle East and Africa is the fastest-growing region at 9.79% annually, supported by new government, financial services and telecom infrastructure.

The United States was the largest country market at $10.77 billion in 2025, equal to 36.2% of global spending. China ranked second at $2.21 billion, followed by Germany at $1.75 billion. India is forecast to grow fastest among the major country markets at 13.49% annually through 2035.

Competitive Landscape Shifts Toward Platform Choice and Migration Economics

The report profiles 16 companies across server virtualization, desktop and application virtualization, management software and services. Broadcom (VMware) is estimated to lead the market with about 39% of 2025 value, while Broadcom, Microsoft and Citrix together account for approximately 58%. Other profiled competitors include Nutanix, Red Hat, Omnissa, Hewlett Packard Enterprise, Oracle, Proxmox Server Solutions, SUSE, Huawei, Scale Computing, Dell Technologies, IBM, Parallels and Canonical.

Recent developments reinforce the move toward broader platform choice. HPE made Morpheus VM Essentials generally available in May 2025, Omnissa announced Horizon support for Nutanix AHV, Broadcom made VMware Cloud Foundation 9.0 generally available in June 2025 and Proxmox released Proxmox VE 9.0 in August 2025. Nutanix reported fiscal 2026 revenue of $2.85 billion and more than 3,000 new customers, reflecting growing interest in alternative virtualization stacks.

Forecast Scenarios Put 2035 Market Between $51.28 Billion and $70.22 Billion

DC Market Insights' base case places the market at $60.90 billion by 2035. A lower-growth scenario, built around faster switching to lower-cost platforms, flat spend per core after 2026 and slower core expansion, produces a $51.28 billion market. A high case, in which bundle pricing remains firm and managed services and edge deployments expand faster, places the market at $70.22 billion.

Kubernetes-native virtualization is a central structural variable in the forecast because it shifts value from the traditional hypervisor license toward container-platform subscriptions and integrated management. For buyers, that makes total cost of ownership, workload portability, governance and operational tooling increasingly important in platform selection.

Research Methodology

DC Market Insights built the market model bottom-up from annual cohorts of virtualized physical cores and concurrent hosted desktop users, with separate pricing curves for hypervisor and management software. Professional and managed services were then added as ratios of software spending. The model was split across five components, three hypervisor types, four deployment models, two organization sizes, seven verticals and five regions. Results were cross-checked against supplier disclosures, published licensing terms and country-level installed server and data center capacity estimates.

Get Free Report Sample - https://www.dcmarketinsights.com/report/data-center-virtualization-market

Report author: Amit Jain, Senior Consultant, ICT & Emerging Technologies. Reviewed by: Deepti Agrawal, Senior Editor, Research.

Related Reports from DC Market Insights

Data Tools by DCMI -

Data Center Map - Deal Tracker - PUE Calculator

About DC Market Insights

DC Market Insights is the data center research and consulting practice of Credence Research, founded in 2015. The firm sizes data center markets, develops forecasts to 2035 and advises investors, operators, vendors and governments on commercial due diligence, site selection, market entry, power strategy, market sizing and competitive intelligence. Its research spans the data center value chain across facilities, power, cooling, racks, cloud, AI compute, interconnection, software, services, storage, networking and energy.

Media and Research Contact

DC Market Insights

Email: [email protected]

United States: +1 628 262 7656

United Kingdom: +44 7453 598 606

Office: Tower C-1105, S 25, Akash Tower, Vishal Nagar, Pimple Nilakh, Pune, MH 411027, India

Web: www.dcmarketinsights.com

SOURCE DC Market Insights

Share this article